{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$7.72 vs. cons $7.60",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "MCR - Cigna Healthcare (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~84.9% vs. cons 84.63%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Evernorth Operating Income (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.80B vs. cons $1.764B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Adj. EPS (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~>=$30.50 vs. cons $30.40",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 MCR Range (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 83.7%-84.7% maintained vs. cons 84.20%",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 Evernorth Income (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide >=$6.9B maintained vs. cons $7.58B",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE - FY raise equals beat flow-through only; no H2 estimate lift; MCR miss trims Q3 MCR assumptions; initial relief rally fades as sell-side works through out-period math",
  "day5_confidence": "MEDIUM"
}